$AES is lowering its 2015 adjusted EPS guidance range to $1.18-1.25 from $1.25-1.35 previously reported guidance. For the full-year 2016, the company expects adjusted EPS to be $1.05-1.15, relative to previous expectation of flat-to-modest growth off the mid-point of prior 2015 guidance of $1.25-1.35.
For 2017, $ENDP expects US Generics base business revenue decline to be similar to 2016 or in the low 30% range. Generics segment sales are expected to decline in the high-single to low-double digit range. In US Generics business, $ENDP estimates to realize approx. $75MM in annual net savings and launch at least 20 products in 2017.
$EQIX agreed for the purchase of ICT-Center AG, Zurich's data center operating business in Zurich, Switzerland for less than $5MM. The agreement was signed on Feb. 1, 2017 and the acquisition is expected to close sometime in early April 2017.